Welcome to the spring edition of the NSCLC Patient Gateway newsletter.
Lung cancer research and treatment are advancing rapidly. Articles in this issue emphasize the critical need for comprehensive biomarker testing at diagnosis or disease progression in patients with NSCLC. This testing, also known as next-generation sequencing or molecular profiling, identifies actionable targets for targeted therapies. We're witnessing targeted therapies not only for advanced stages but also in early-stage NSCLC.
Immunotherapy is another significant aspect discussed, offering benefits across different racial groups. Exciting developments include vaccines and antibody-drug conjugates (ADCs), a new class of drugs targeting cancer cells more precisely. While ADCs face challenges in NSCLC and SCLC, they hold promise for future treatment options.
Explore these advances in lung cancer research in the articles below.
Research News
Pharmacy Times
Phase 3 Trials Demonstrate Efficacy of Immune Checkpoint Inhibitors for Lung Cancer in Older Adults
Published Jan 26, 2024
OncLive
Dr Kareff on the Utility of ADCs in NSCLC
Published Apr 4, 2024
MEEFRO
Touchlight joins forces with University of Liverpool for NSCLC vaccine
Published Apr 4, 2024
ZENUZZ
Dr Bazhenova on the Need for Comprehensive Molecular Testing in Unresectable NSCLC
Published Jan 21, 2024
99.5 & 105.9 JAMZ
Lung cancer treatment by stage explained
Published Dec 29, 2023
Healio
First-line immunotherapy benefits patients of all races with NSCLC equally
Published Dec 22, 2023
JAMA Network
Biomarker Testing in Patients With Unresectable Advanced or Recurrent Non–Small Cell Lung Cancer
Published Dec 15, 2023
CURE
Next-Generation Sequencing Helps ‘Select the Best Treatment’ for Lung Cancer
Published Dec 15, 2023
Get Connected
Join Us for the NSCLC Virtual Meetup
This is an easy way to build your community. On the second Wednesday of each month, you can connect with others who understand what it’s like to live with NSCLC. The next NSCLC Meetup is happening on Wednesday, May 8, 2024, at 12 pm ET. Register for this virtual meetup to get a confirmation email with details about how to join the virtual meeting. New attendees are always welcome and encouraged to join!
Can’t make it? Don’t worry, there’s a full list of virtual meetups to fit your schedule.
Last Call for 2024 HOPE Summit in Atlanta
Join us in Atlanta for this free conference May 3-5, 2024. This family-friendly event for patients and caregivers features inspirational speakers and lung cancer experts to answer questions and offer tips for addressing the everyday issues that come up for people living with lung cancer. Don’t miss this opportunity to hear directly from lung cancer survivors and caregivers who have a firsthand view of what it is like to survive and thrive after a lung cancer diagnosis. Because lung cancer affects the whole family, we will also have special activities for kids in collaboration with Camp Kesem and Pickles Group.
Learn more
Have You Seen?
Cancer Grand Challenges Summit 2024: No Time to Waste in Addressing Some of the Toughest Challenges in Cancer
LUNGevity's Dr. Amy Moore just returned from the Cancer Grand Challenges Summit, held March 5–8, 2024 in London, England. Cancer Grand Challenges was launched in 2020 as a collaboration between Cancer Research UK and the National Cancer Institute in the US to build global collaborations that address the most perplexing issues in cancer.
Read the article here
Treatment of Advanced-Stage NSCLC Without Targetable Biomarkers
Interested in learning more about the treatment of metastatic NSCLC without targetable biomarkers? In this webinar, you will hear from guest speakers Denise Cutlip (patient advocate) and Benjamin Levy, MD (thoracic oncologist & clinical director of medical oncology, Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital). Dr. Levy is a physician-scientist who runs clinical trials in lung cancer and serves as a member of LUNGevity's Scientific Advisory Board.
Watch the video here
Chemo Shortage Didn't Materialize the Way We Initially Feared
In March, LUNGevity Foundation partnered with CURE for their “Speaking Out” video series, inviting Amy Moore, PhD, vice president of global engagement and patient partnerships at LUNGevity Foundation, to discuss recent chemotherapy shortages. Her expertise provides essential understanding for anyone interested in the complexities of lung cancer treatment amid shortages.
Visit our partners at CURE to watch the complete interview
Helpful Apps for People Living with Lung Cancer
As smartphones have become a large part of our lives, we have an opportunity to use technology to help us manage a cancer diagnosis. Take a look at this list of helpful apps to consider when managing a lung cancer diagnosis.
Read it here
…and there is always so much more to explore on the NSCLC Patient Gateway.
If you were forwarded this email and you’d like to subscribe to this newsletter, you can sign up here.
If you need further assistance along your lung cancer journey, please email us at support@lungevity.org. Our team is always here to assist you.
